4.4 Article

Expression of Semenogelins I and II and Its Prognostic Significance in Human Prostate Cancer

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Dietary Zinc and Prostate Cancer in the TRAMP Mouse Model

Ananda S. Prasad et al.

JOURNAL OF MEDICINAL FOOD (2010)

Article Oncology

Cancer Statistics, 2009

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2009)

Article Oncology

Biomolecular Markers of Outcome Prediction in Prostate Cancer

Alessia Lopergolo et al.

CANCER (2009)

Article Oncology

Promotion of bladder cancer development and progression by androgen receptor signals

Hiroshi Miyamoto et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Ophthalmology

Characterization of semenogelin proteins in the human retina

Vera L. Bonilha et al.

EXPERIMENTAL EYE RESEARCH (2006)

Review Biochemistry & Molecular Biology

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots

Leslie C. Costello et al.

MOLECULAR CANCER (2006)

Article Biochemistry & Molecular Biology

Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen

M Jonsson et al.

BIOCHEMICAL JOURNAL (2005)

Article Oncology

Zinc supplement use and risk of prostate cancer

MF Leitzmann et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

Article Developmental Biology

Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues

Å Lundwall et al.

MOLECULAR HUMAN REPRODUCTION (2002)